On October 9, 2017, California Gov. Jerry Brown signed SB 17, which requires pharmaceutical companies to notify the state and health insurers each time they plan to raise the price of a medication by 16 percent or more over two years. And, interestingly, each pharma company will need to provide justification for the price hike.

“Californians have a right to know why their medical costs are out of control, especially when pharmaceutical profits are soaring,” Brown told NPR. “This measure is a step at bringing transparency, truth, exposure to a very important part of our lives, that is the cost of prescription drugs.”

… continue reading Drug Pricing Transparency California Bill Passes, Others Awaiting Signatures